Tue, 05/02/2023 - 12:00 Publications Étude Fièvre Jaune Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in HIV-infected people in Kenya (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial Share Share on Facebook Share on Telegram Share on LinkedIn Share on Twitter Copy link Page url is copied Read on Lancet Infectious Diseases Newsroom Read more 08 Apr 2024 Vidéos Reportage in Haydan, Yemen, on the development of the rehabilitation care in the MSF sites. 12 Feb 2024 On parle de nous Antibiogo Antibiogo in Harvard Public Health magazine 28 Nov 2023 Vidéos Antibiogo 1 year after its routine implementation, where does Antibiogo stand? Interview with Dr Nada Malou
08 Apr 2024 Vidéos Reportage in Haydan, Yemen, on the development of the rehabilitation care in the MSF sites.
28 Nov 2023 Vidéos Antibiogo 1 year after its routine implementation, where does Antibiogo stand? Interview with Dr Nada Malou